首页> 美国卫生研究院文献>Cardiorenal Medicine >Neuronal Nitric Oxide Synthase-Dependent Amelioration of Diastolic Dysfunction in Rats with Chronic Renocardiac Syndrome
【2h】

Neuronal Nitric Oxide Synthase-Dependent Amelioration of Diastolic Dysfunction in Rats with Chronic Renocardiac Syndrome

机译:神经元一氧化氮合酶依赖改善慢性肾病综合征大鼠舒张功能障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have recently described the chronic renocardiac syndrome (CRCS) in rats with renal failure, cardiac dysfunction and low nitric oxide (NO) availability by combining subtotal nephrectomy and transient low-dose NO synthase (NOS) inhibition. Cardiac gene expression of the neuronal isoform of NOS (nNOS) was induced. Hence, we studied the role of nNOS, in vivo cardiac function and β-adrenergic response in our CRCS model by micromanometer/conductance catheter. Left ventricular (LV) hemodynamics were studied during administration of dobutamine (dobu), the highly specific irreversible inhibitor of nNOS L-VNIO [L-N5-(1-Imino-3-butenyl)-ornithine], or both at steady state and during preload reduction. Rats with CRCS showed LV systolic dysfunction at baseline, together with prolonged diastolic relaxation and rightward shift of the end-systolic pressure-volume relationships. After L-VNIO infusion, diastolic relaxation of CRCS rats further prolonged. The time constant of active relaxation (tau) increased by 25 ± 6% from baseline (p < 0.05), and the maximal rate of pressure decrease was 36 ± 7% slower (p < 0.001). These variables did not change in controls. In our CRCS model, nNOS did not seem to affect systolic dysfunction. In summary, in this model of CRCS, blockade of nNOS further worsens diastolic dysfunction and L-VNIO does not influence inherent contractility and the response to dobu stress.
机译:我们最近通过合并小计肾切除术和短暂性低剂量一氧化氮合酶(NOS)抑制作用,描述了患有肾衰竭,心脏功能障碍和一氧化氮(NO)利用率低的大鼠的慢性肾病综合征(CRCS)。诱导了NOS(nNOS)的神经元亚型的心脏基因表达。因此,我们通过微压力计/电导导管研究了nNOS,体内心脏功能和β-肾上腺素能反应在CRCS模型中的作用。研究了多巴酚丁胺(dobu)的左心室(LV)血流动力学,多巴酚丁胺是一种高度特异性的nNOS L-VNIO [L-N5-(1-Imino-3-butenyl)-鸟氨酸]的不可逆抑制剂,或在稳态和在减少预载期间。患有CRCS的大鼠在基线时表现为LV收缩功能障碍,同时舒张期舒张时间延长和收缩末期压力-容积关系向右移动。 L-VNIO输注后,CRCS大鼠的舒张期舒张进一步延长。主动放松的时间常数(tau)与基线相比增加了25±6%(p <0.05),最大压力降低速度减慢了36±7%(p <0.001)。这些变量在控件中没有改变。在我们的CRCS模型中,nNOS似乎并未影响收缩功能障碍。总之,在这种CRCS模型中,对nNOS的阻滞进一步加重了舒张功能障碍,L-VNIO不会影响固有的收缩力和对dobu应激的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号